Harch_HBOT_LogoHarch_HBOT_LogoHarch_HBOT_LogoHarch_HBOT_Logo
  • About
    • Paul G Harch MD
      • Bio
      • Curriculum Vitae
    • Our Team
    • Our Service
    • Our Process
  • Hyperbaric Oxygen Therapy
    • What is HBOT?
    • What are the benefits?
    • Can HBOT help you?
    • FAQ’s
  • Conditions
    • Alzheimer’s
    • Arthritis
    • Autism
    • Autoimmune Disorders
    • Bell’s Palsy 
    • Birth Injuries 
    • Burn Injuries 
    • Cerebral Palsy
    • Drowning and Anoxic Brain Injury
    • HBOT for Brain Aneurysm 
    • HBOT of Brain Injury Caused by Substance Abuse 
    • Herpes of the Brain
    • Migraine Headache
    • Mild Cognitive Impairment (MCI) and Dementia
    • Multiple Sclerosis
    • Plastic-Cosmetic Surgery
    • Recovery from Surgery
    • Sports Injuries and Sports Performance/Recovery
    • Stroke
    • Traumatic Brain Injury
  • The Science
    • Published Research
    • Case Studies
    • Lectures
    • Interviews
    • Hyperbaric Therapy and Hyperbaric Oxygen Therapy: New Scientific Definitions
    • SPECT Imaging
      • What is SPECT?
      • SPECT Case Study PDFs
    • SPECT Case Study PDFs
      • The Book
      • The Oxygen Revolution Third Edition Links
  • Press
    • Latest News
    • Media
    • Current Events
    • Testimonials
  • Contact
✕
  • Home
  • The Science Behind HBOT
  • COVID19
  • Alternative Therapies in Health and Medicine Interview with Dr. Harch: HBOT and Coronavirus Application.
Safety Procedures HBOT Coronavirus
Safety and Infection Control Procedures for HBOT of Coronavirus Patients
May 18, 2020
Using Hyperbaric Oxygen Therapy for Coronavirus Lung Infection
Joe Thomas in the Morning – Interview with Dr. Harch on COVID-19
June 8, 2020
Published by Edward on June 7, 2020
Categories
  • COVID19
  • Media & Lectures
  • News
  • The Science Behind Patient Improvement With HBOT
Tags
IHMA award

Alternative Therapies in Health and Medicine Interview with Paul G. Harch M.D.

Alternative Therapies in Health and Medicine (ATHM): To start can you provide me a little bit about your background.

Dr. Harch: I went to college at the University of California Irvine and then medical school at Johns Hopkins. After medical school I went to the University of Colorado and did two years of general surgery training, an additional year of radiology training in New Orleans at LSU Charity Hospital and then while I was in New Orleans had a practice-based experience of emergency medicine.  The second year I was in New Orleans, 1985, I joined a group that had a large hyperbaric chamber and received all of the diving medicine referrals for the Gulf of Mexico. Part of that practice also was wound care. So it was a hyperbaric medicine practice. I went and received training in hyperbaric medicine from the federal government and made a discovery treating our divers from the Gulf of Mexico that involved brain decompression illness, which was pretty much ignored for most of its existence or at least a hundred years in the diving medicine field.

Importantly, we found a way that we could image and treat brain decompression illness. It turns out 80% of decompression sickness is neurological, it’s not the joint “bends.”  We found that we could treat these divers with brain involvement weeks, months, or long after it was considered treatable and capture the results on very illustrative brain blood flow scans.  Prior to this discovery it was understood that you had to treat divers within 24 hours of the injury or it was permanent.  Once we made that discovery in divers, we started treating some Louisiana boxers and then the first cerebral palsy children, autistic children, people with stroke, toxic brain injury, and over the years now, probably 90 different neurological diagnoses. I’ve done this in both formal animal and human studies and as a clinical application.  The research studies included the first veterans with TBI and PTSD and in March we published a randomized trial of HBOT in the treatment of traumatic brain injury post-concussion syndrome in civilians and veterans.  Also, in March I brought to the public’s attention that we very likely could treat dying patients with coronavirus which brings us up to today.

…

ATHM: Let’s talk a little bit about the Coronavirus because that’s the topic that’s hot right now. How does hyperbaric oxygen therapy relate to it?

Dr. Harch: Well, it corrects what people are dying of, which is low oxygen in the blood, and treats the underlying disease in the lungs.  Patients who are in the process of deteriorating and going on a ventilator are the best candidates.  If people get the infection and a certain percentage of them proceed to very serious lung infection, there’s a point in the process where, and it’s not clear why, the ones with the risk factors go downhill in a hurry.  Generally it’s over about a 48 hour period and or even less. Sometimes it is in just an hour or so. And when they do deteriorate it is due to an intense inflammatory reaction in their lungs.  Eventually, they die of low oxygen level s that cause end organ damage, such as heart, brain, kidney damage, and multiorgan failure.

Continue with the interview here

Share
0
Edward
Edward

Related posts

May 9, 2025

Chronic Fatigue Syndrome (CFS) and Immunotherapy: Emerging Treatment Directions


Read more
May 1, 2025

Hyperbaric Oxygen Therapy for TBI, PTSD & Depression (HBOT Benefits)


Read more
January 22, 2025

Drowned Baby Arthur Comes to Harch Hyperbarics Inc.


Read more

Leave a Reply Cancel reply

You must be logged in to post a comment.

CONTACT INFORMATION

Address:
3409 Division St., Suite 201
Metairie, LA 70002
Phone:
504-309-4948
E-mail:
[email protected]
BUSINESS HOURS:
Monday - Friday: 9:00 am - 4:00 pm
Saturday - Sunday: CLOSED
Connect with us:
   
PWD FRIENDLY:
Harch Hyperbarics in Metairie has comfortable handicap accessible accommodations:
• Handicap parking with ramp • Large elevator
• 2 Large handicap accessible bathrooms • Hoyer lift
• Wide hallways for easy navigation with a stretcher
© 2025 Copyright Harch HBOT. All rights reserved.